Establishment Labs Holdings Inc. announced its financial results for the third quarter ended September 30, 2024. The company reported total revenue of $40.2 million for the quarter, representing a 4.5% increase compared to the same period in 2023.
Despite the revenue growth, Establishment Labs reported a net loss of $20.5 million for the third quarter. This net loss was a slight decrease of 1.5% from the net loss reported in the third quarter of 2023.
The company continues to focus on its global medical technology business, primarily in breast aesthetics and reconstruction. These results provide an update on the company's financial standing as it continues to expand its product portfolio and market presence.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.